Your Patients Can't Find Their Bimatoprost — Here's How Your Practice Can Help

You've prescribed Bimatoprost for a glaucoma patient, but they call back a few days later: "My pharmacy says it's on backorder." Or worse — they simply don't fill it and show up at their next visit with elevated IOP and no explanation.

Medication access issues are increasingly common in ophthalmology, and Bimatoprost is no exception. While the drug is not formally in shortage according to the FDA, intermittent pharmacy-level stock disruptions have been a persistent challenge throughout 2025 and into 2026. As a prescriber, you're in a unique position to help patients navigate these barriers before they lead to gaps in treatment.

This guide provides five practical steps your practice can take, along with alternative medication options and workflow tips to keep your patients on track.

Current Bimatoprost Availability

Here's the quick picture as of early 2026:

• Generic Bimatoprost 0.03%: Generally available at most pharmacies
• Generic Bimatoprost 0.01%: Improving — Amneal's newly approved generic is entering the market, but distribution is still expanding
• Brand Lumigan (0.01%): Available but often on backorder at individual pharmacies; high cash price ($200-$300+) limits demand
• Durysta implant: Available through buy-and-bill; not subject to pharmacy shortages

For a full timeline and analysis, see our provider shortage briefing.

Why Patients Can't Find Bimatoprost

Before jumping to solutions, it helps to understand the common reasons patients face access barriers:

1. Pharmacy Stocking Gaps

Chain pharmacies use automated ordering systems that prioritize high-volume medications. Bimatoprost — a specialty ophthalmic product — may not be routinely stocked, especially at pharmacies that don't serve a large glaucoma patient population. The patient arrives, the pharmacy doesn't have it, and the waiting begins.

2. Insurance and Formulary Barriers

Many commercial and Medicare plans now require step therapy (typically Latanoprost first) or prior authorization for Bimatoprost. If the PA isn't submitted promptly, the patient faces delays at the pharmacy. Some plans have also moved brand Lumigan to non-preferred tiers, creating cost barriers that patients interpret as "unavailability."

3. Concentration Confusion

Bimatoprost comes in 0.01% and 0.03% concentrations. If the prescription specifies one concentration and the pharmacy only stocks the other, the prescription can't be filled without provider intervention. This is a solvable problem that your practice can address proactively.

4. Cost as a Hidden Barrier

Generic Bimatoprost costs $50-$120 without insurance. Patients who can't afford this may not tell you directly — they simply don't fill the prescription. AbbVie's Lumigan co-pay program and discount cards can help, but patients need to be directed to these resources.

What Providers Can Do: 5 Practical Steps

Step 1: Verify Pharmacy Stock Before Prescribing

Before sending a Bimatoprost prescription, check whether the patient's preferred pharmacy is likely to have it. You can:

• Direct your staff to use Medfinder to check real-time pharmacy availability
• Ask the patient to verify stock with their pharmacy before you send the e-prescription
• Maintain a list of local pharmacies that reliably stock ophthalmic prostaglandin analogs

Step 2: Prescribe Flexibly When Possible

To minimize fill failures:

• Allow generic substitution on the prescription
• Consider noting "0.01% or 0.03% per availability" in the prescription comments (if clinically appropriate for the patient)
• If the patient uses a chain pharmacy with frequent stock issues, suggest they try an independent or specialty pharmacy

Step 3: Submit Prior Authorizations Proactively

If the patient's insurance requires PA for Bimatoprost:

• Submit the PA at the time of prescribing, not after the pharmacy reports a rejection
• Document clinical rationale clearly: Latanoprost trial and failure/intolerance, specific IOP targets, etc.
• Use electronic PA tools integrated with your EHR to streamline the process

Step 4: Provide Cost and Access Resources

Equip your patients with the information they need to afford and find their medication:

• Discount cards: GoodRx and SingleCare can reduce generic Bimatoprost to $1-$57
• AbbVie co-pay savings: Up to $2,640/year for commercially insured patients using Lumigan (savewithays.com)
• Patient Assistance Program: Allergan PAP through AbbVie provides free medication to qualifying uninsured patients
• Medfinder: Direct patients to medfinder.com for pharmacy stock searches and savings resources

Step 5: Have a Backup Plan Ready

Before the patient leaves your office, establish a contingency plan in case they can't fill Bimatoprost:

• Identify which alternative prostaglandin analog you would switch to (typically Latanoprost as the most available and affordable option)
• Write a backup prescription or note in the chart so the patient doesn't need another appointment to switch
• Set a follow-up check-in (phone or portal message) within 1-2 weeks to confirm the prescription was filled

Alternative Medications to Consider

When Bimatoprost is unavailable or unaffordable, the following prostaglandin analogs are clinically appropriate alternatives for most patients:

• Latanoprost (Xalatan): Most widely available and affordable option; $10-$25 with discount cards; comparable IOP-lowering efficacy; lower hyperemia rates
• Travoprost (Travatan Z): Comparable efficacy; sofZia preservative system (BAK-free); generic available at $15-$50 with coupons
• Tafluprost (Zioptan): Preservative-free in unit-dose vials; ideal for BAK-sensitive patients; $50-$150 with discounts
• Latanoprostene Bunod (Vyzulta): Dual-mechanism (prostaglandin + nitric oxide); brand-only; $150-$300+; consider for patients needing enhanced IOP reduction
• Durysta implant: Eliminates pharmacy availability concerns; single in-office administration; covered under medical benefits; AbbVie savings program available

For a patient-facing comparison, share our guide on alternatives to Bimatoprost.

Workflow Tips for Your Practice

Incorporate these habits to reduce medication access issues across your patient panel:

• Prescription fill tracking: Flag patients who haven't picked up prescriptions within 7-10 days for outreach
• Pharmacy relationship management: Build relationships with 2-3 local pharmacies (including at least one independent) that reliably stock ophthalmic medications
• Patient education handouts: Create or print handouts with savings program information, Medfinder instructions, and alternative medication options
• EHR smart phrases: Build templates for PA letters, backup prescription notes, and patient instructions for medication access challenges
• Staff training: Ensure front desk and support staff know how to use Medfinder, process PAs, and guide patients to savings programs

Final Thoughts

Medication access is now a clinical workflow issue, not just a patient responsibility. When a glaucoma patient can't fill their Bimatoprost prescription, the downstream consequences — missed doses, IOP elevation, disease progression — fall on both the patient and the care team.

By proactively verifying stock, prescribing flexibly, submitting PAs early, sharing cost resources, and having a backup plan, your practice can significantly reduce the risk that supply issues translate into treatment gaps. Tools like Medfinder make it easier than ever to stay ahead of availability challenges.

For the patient perspective on this issue, see our companion articles: Why Is Bimatoprost So Hard to Find? and Bimatoprost Shortage Update for Patients.